A potent and highly selective nonpeptidyl nociceptin/orphanin FQ receptor (ORL1) antagonist: J-113397

Citation
S. Ozaki et al., A potent and highly selective nonpeptidyl nociceptin/orphanin FQ receptor (ORL1) antagonist: J-113397, EUR J PHARM, 387(3), 2000, pp. R17-R18
Citations number
7
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
387
Issue
3
Year of publication
2000
Pages
R17 - R18
Database
ISI
SICI code
0014-2999(20000117)387:3<R17:APAHSN>2.0.ZU;2-V
Abstract
We discovered a potent nociceptin/orphanin FQ receptor (ORL1) receptor anta gonist, J-113397 (1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl ]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one). J-113397 inhibited [I-125][Ty r(14)]nociceptin binding to Chinese hamster ovary (CHO) cells expressing OR L1 receptor in a dose-dependent manner (IC50; 2.3 nM), but showed 600-fold or less affinity for mu-, delta- and kappa-opioid receptors. Nociceptin/orp hanin FQ-induced suppression of cyclic AMP accumulation elicited by forskol in was completely inhibited by J-113397 with an IC50 value of 26 nM. These results indicate that J-113397 is a potent and selective nonpeptidyl antago nist of the ORL1 receptor. (C) 2000 Elsevier Science B.V. All rights reserv ed.